Simple jQuery Dropdowns

Browsing by Author Mark S. De Souza

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
31-Mar-2005Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in ThailandChitraporn Karnasuta; Robert M. Paris; Josephine H. Cox; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Arthur E. Brown; Sanjay Gurunathan; James Tartaglia; William L. Heyward; John G. McNeil; Deborah L. Birx; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; U.S. Military HIV Research Program; Mahidol University; Sanofi Pasteur SA; Aventis Pasteur; VaxGen, Inc.
1-May-2017Comparison of antibody responses induced by RV144, VAX003, and VAX004 vaccination regimensChitraporn Karnasuta; Siriwat Akapirat; Sirinan Madnote; Hathairat Savadsuk; Jiraporn Puangkaew; Surawach Rittiroongrad; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; James Tartaglia; Faruk Sinangil; Donald P. Francis; Merlin L. Robb; Mark S. De Souza; Nelson L. Michael; Jean Louis Excler; Jerome H. Kim; Robert J. O'connell; Nicos Karasavvas; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; Mahidol University; Sanofi Pasteur; Global Solutions for Infectious Diseases; Walter Reed Army Institute of Research; HJF; Thai Red Cross AIDS Research Centre; International Vaccine Institute, Seoul
15-Apr-2013Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm; Robert M. Paris; Supamit Chunsutthiwat; Nakorn Premsri; Chawetsan Namwat; Chureeratana Bowonwatanuwong; Shuying S. Li; Jaranit Kaewkungkal; Rapee Trichavaroj; Nampueng Churikanont; Mark S. De Souza; Charla Andrews; Donald Francis; Elizabeth Adams; Jorge Flores; Sanjay Gurunathan; Jim Tartaglia; Robert J. O'Connell; Chirapa Eamsila; Sorachai Nitayaphan; Viseth Ngauy; Prasert Thongcharoen; Prayura Kunasol; Nelson L. Michael; Merlin L. Robb; Peter B. Gilbert; Jerome H. Kim; Thailand Ministry of Public Health; US Military HIV Research Program; Chonburi Regional Hospital; Fred Hutchinson Cancer Research Center; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Royal Thai Army
1-Aug-2003Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patientsVictoria R. Polonis; Mark S. De Souza; Janice M. Darden; Somsak Chantakulkij; Thippawan Chuenchitra; Sorachai Nitayaphan; Arthur E. Brown; Merlin L. Robb; Deborah L. Birx; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; HJF; Walter Reed Army Institute of Research
10-Feb-2015Identification of immunodominant cd4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B/ESilvia Ratto-Kim; Mark S. De Souza; Jeffrey R. Currier; Nicos Karasavvas; John Sidney; Morgane Rolland; Anais Valencia-Micolta; Sirinan Madnote; Alessandro Sette; Sorachai Nitayaphan; Punnee Pitisuttuthum; Jaranit Kaewkungwal; Supachai Rerks-Ngarm; Robert O'Connell; Nelson Michael; Merlin L. Robb; Mary Marovich; Jerome H. Kim; Walter Reed Army Institute of Research; Armed Forces Research Institute of Medical Sciences, Thailand; La Jolla Institute for Allergy and Immunology; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; National Institute of Infectious Diseases; Water Reed Army Institute of Research
1-Nov-2015IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas; Chitraporn Karnasuta; Hathairat Savadsuk; Sirinan Madnote; Dutsadee Inthawong; Somsak Chantakulkij; Surawach Rittiroongrad; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Vinai Siriyanon; Charla A. Andrews; Susan W. Barnett; James Tartaglia; Faruk Sinangil; Donald P. Francis; Merlin L. Robb; Nelson L. Michael; Viseth Ngauy; Mark S. De Souza; Robert M. Paris; Jean Louis Excler; Jerome H. Kim; Robert J. O'Connell; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Chiang Mai University; TECHNICAL RESOURCES INTERNATIONAL, INC.; NOVARTIS VACCINES AND DIAGNOSTICS, INC.; Sanofi Pasteur; Global Solutions for Infectious Diseases; Walter Reed Army Institute of Research; HJF; International Vaccine Institute, Seoul
5-Apr-2012Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F. Haynes; Peter B. Gilbert; M. Juliana McElrath; Susan Zolla-Pazner; Georgia D. Tomaras; S. Munir Alam; David T. Evans; David C. Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua Xin Liao; Anthony L. DeVico; George K. Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L. Robb; Viseth Ngauy; Mark S. De Souza; Robert Paris; Guido Ferrari; Robert T. Bailer; Kelly A. Soderberg; Charla Andrews; Phillip W. Berman; Nicole Frahm; Stephen C. De Rosa; Michael D. Alpert; Nicole L. Yates; Xiaoying Shen; Richard A. Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; NYU School of Medicine; Harvard Medical School; Walter Reed Army Institute of Research; National Institute of Allergy and Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Royal Thai Army; Faculty of Medicine, Siriraj Hospital, Mahidol University; Mahidol University; Thailand Ministry of Public Health; University of California, Santa Cruz; University of Maryland School of Medicine; Rutgers New Jersey Medical School
1-Apr-2003Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progressionThippawan Chuenchitra; Victoria R. Polonis; Chantapong Wasi; Suda Louisirirojchanakul; Sorachai Nitayaphan; Ruengpung Sutthent; Josephine H. Cox; Mark S. De Souza; Arthur E. Brown; Deborah L. Birx; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; HJF; Walter Reed Army Institute of Research
1-Aug-2012Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trialsDavid C. Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S. De Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M. Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C. Labranche; Charla Andrews; Victoria R. Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G. Self; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L. Robb; Barton F. Haynes; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Armed Forces Research Institute of Medical Sciences, San Francisco; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; University of Alabama; Ministry of Public Health; Mahidol University; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Sanofi Pasteur
1-Sep-2007A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boostPrasert Thongcharoen; Vinai Suriyanon; Robert M. Paris; Chirasak Khamboonruang; Mark S. De Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R. Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E. Brown; Deborah L. Birx; John G. McNeil; Jerome H. Kim; Faculty of Medicine, Siriraj Hospital, Mahidol University; Chiang Mai University; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Sanofi Pasteur; Sanofi Pasteur SA; Novartis Vaccines and Diagnostics, Inc.; US Army Medical Materiel Development Activity; Centers for Disease Control and Prevention; PATH Malaria Vaccine Initiative; Mahidol University
19-Mar-2014Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccinesAmy W. Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne Sophie Dugast; Matthew K. Schoen; Morgane Rolland; Todd J. Suscovich; Alison E. Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S. De Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L. Michael; Jerome H. Kim; Chris Bailey-Kellogg; Margaret E. Ackerman; Galit Alter; Massachusetts Institute of Technology; Thayer School of Engineering at Dartmouth; Dartmouth College; Walter Reed Army Institute of Research; Duke University; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Global Solutions for Infectious Diseases
1-Nov-2012The thai phase III HIV type 1 vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T. Bailer; Richard A. Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D. Tomaras; Jeffrey R. Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J. Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T. Korber; David C. Montefiori; John R. Mascola; Merlin L. Robb; Barton F. Haynes; Viseth Ngauy; Nelson L. Michael; Jerome H. Kim; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Walter Reed Army Institute of Research; NYU School of Medicine; Veterans Affairs NY Harbor Healthcare System; National Institute of Allergy and Infectious Diseases; Duke University School of Medicine; Fred Hutchinson Cancer Research Center; Thailand Ministry of Public Health; Mahidol University; Walter Reed National Military Medical Center; Sanofi Pasteur; Global Solutions for Infectious Diseases; Los Alamos National Laboratory
15-May-2012The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S. De Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M. Paris; Jaranit Kaewkungwal; Nelson L. Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R. Currier; Jerome H. Kim; Supamit Chunsuttiwat; Nakorn Premsri; Chawetsan Namwat; Prayura Kunasol; Prasert Thongcharoen; Chirasak Khamboonruang; Valai Bussaratid; Wirach Maek-a-nantawat; Jittima Dhitavat; Pravan Suntharasamai; Swangjai Pungpak; Siriwan Vanijanonta; Jaranit Kaewkunwal; Amnat Khamsiriwatchara; Pawinee Jarujareet; Chirapa Easmila; Suchana Tabprasit; Viseth Ngauy; Robert Paris; Michael Benenson; Patricia Morgan; Arthur Brown; Mark De Souza; Rapee Trichavaroj; Nusara Thaitawat; Kanyasiri Kongnonkok; Boot Keawboon; Yuwadee Phuang-Ngern; Susan Mason; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Robin Harkness; Claude Meric; Lynn Baglyos; Raphaelle El Habib; Don Francis; Carter Lee; Elizabeth Adams; Merlin L. Robb; Mark Milazzo; Amy Bolen; Beryl Wessner; Jeffrey Currier; Deborah L. Birx; Don Stablein; Terry Germanson; Len Dally; Jean Louis Excler; Jeffrey Berenberg; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; Sanofi Pasteur; Sanofi Pasteur; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; U.S. Army Medical Research and Materiel Command; Centers for Disease Control and Prevention; The EMMES Corporation; International AIDS Vaccine Initiative; Tripler Regional Med Center